cancer diagnostics | sciencenewsnet.in

Breaking News

ADDMAN Secures Qualification Project for CuNi Submarine Fittings with the US Navy

It’s easier now to treat opioid addiction with medication — but use has changed little

Researchers Publish Final Results of Key Clinical Trial for Gene Therapy for Sickle Cell Disease

A new report from the American Lung Association shows nearly 40% of people across the U.S. are living in areas that are heavily polluted.

Five facilities at Argonne where climate solutions are front and center

Use of Acid Reflux Drugs Linked to Higher Risk of Migraine

For Immigrants to Canada, Risk of MS Increases with Proportion of Life Spent There

Sweet potato quality analysis is enhanced with hyperspectral imaging and AI

The Medical Minute: Supervised exercise therapy eases symptoms of peripheral artery disease

Detection of Missed Colorectal Cancer Remains Low for Most Diverticulitis Patients

25 Apr, 2024

Researchers Design Multiclass Cancer Diagnostic Tool Using AI, MicroRNA

July 20, 2023 sarah JonasResearch Results

MicroRNAs, or miRNAs, regulate genes and biological processes in the human body, including cancer formation and development. To explore the feasibility of miRNAs as cancer biomarkers, researchers created a multiclass cancer diagnostic model using miRNA expression profiles. The study examined the relationship between the composition of miRNAs and various types of cancers. Findings suggest that miRNAs may be highly unique to specific cancerous tissues and can be strong biomarkers for detection and classification in both research and the clinical field

Scientists Recruit New Atomic Heavyweights in Targeted Fight Against Cancer

December 14, 2020 sarah JonasResearch Results

Researchers from Berkeley Lab and Los Alamos National Laboratory have developed new methods for the large-scale production, purification, and use of the radioisotope cerium-134, which could serve as a PET imaging radiotracer for a highly targeted cancer treatment known as alpha-particle therapy.

Phosphoprotein biomarkers to guide cancer therapy are identified

July 28, 2020 sarah JonasResearch Results

Post-translational modification analysis may broadly identify new biomarkers of cancer drivers for a much more precise prediction of patient responses to treatments. A recent study demonstrates this diagnostic alternative for neuroendocrine neoplasms driven by a protein kinase called Cdk5.